4/A
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-08-015120
Chief Financial Officer acquired 44,795 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CULPEPPER PETER R · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2008-06-12 | Exercise or conversion : show line 1 in the form | +44,795 | $1.10 | $49,275 | 260,376 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2008-06-12 | Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) | −44,795 | $1.10 | 2014-02-25 | 44,795 | 189,624 | D |
Loading xslF345X02/doc1.xml…